Elite Wins FDA Nod

Elite Wins FDA Nod

By: Dylan Sikes – AllPennyStocks.com News

Thursday, September 12, 2019

With the problem of opioid-related deaths becoming an even bigger concern, companies and products fighting such addiction certainly deserve attention. 

Northvale, New Jersery-based Elite Pharmaceuticals, Inc. (OTC:ELTP) is a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products. The company came out Thursday with the news of approval from the U.S. Food and Drug Administration for an Abbreviated New Drug Application for a generic version of Tylenol® with Codeine (acetaminophen and codeine phosphate) 300mg/15mg, 300mg/30mg, and 300mg/60mg tablets.

Elite is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. 

Shares in ELTP popped 67-100ths of a cent, or 9.1%, to eight cents, on volume of 753,000.

Copyright © 2019 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon

Other Penny Stock Movers

Pot Stock Recovery? This One Jumped on Friday
Noram Hails Upcoming Nevada Projects, Stocks Travel Higher
Tech Shares Lead Charge Out of Monday-Tuesday Gully
Two Cannabis Firms in Spotlight During Gloomy Week for Stocks

Back to Top